MiMedx Group, Inc. (MDXG)
4.545
+0.04
(+1.00%)
USD |
NASDAQ |
Aug 31, 16:00
4.545
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Cash from Operations (TTM) : 46.13M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.13M |
| March 31, 2026 | 70.58M |
| December 31, 2025 | 74.00M |
| September 30, 2025 | 68.93M |
| June 30, 2025 | 59.22M |
| March 31, 2025 | 66.62M |
| December 31, 2024 | 66.20M |
| September 30, 2024 | 56.57M |
| June 30, 2024 | 49.74M |
| March 31, 2024 | 35.70M |
| December 31, 2023 | 26.78M |
| September 30, 2023 | 10.89M |
| June 30, 2023 | -0.938M |
| March 31, 2023 | -11.72M |
| December 31, 2022 | -17.89M |
| September 30, 2022 | -15.50M |
| June 30, 2022 | -10.13M |
| March 31, 2022 | -5.526M |
| December 31, 2021 | -1.982M |
| September 30, 2021 | -9.017M |
| June 30, 2021 | -19.96M |
| March 31, 2021 | -24.66M |
| December 31, 2020 | -30.26M |
| September 30, 2020 | -43.12M |
| June 30, 2020 | -41.66M |
| Date | Value |
|---|---|
| March 31, 2020 | -36.43M |
| December 31, 2019 | -39.41M |
| September 30, 2019 | -14.76M |
| June 30, 2019 | -8.199M |
| March 31, 2019 | 10.36M |
| December 31, 2018 | 35.80M |
| September 30, 2018 | 55.13M |
| June 30, 2018 | 69.68M |
| March 31, 2018 | 62.48M |
| December 31, 2017 | 62.94M |
| September 30, 2017 | 58.83M |
| June 30, 2017 | 43.68M |
| March 31, 2017 | 37.42M |
| December 31, 2016 | 25.80M |
| September 30, 2016 | 13.40M |
| June 30, 2016 | 17.91M |
| March 31, 2016 | 13.62M |
| December 31, 2015 | 18.81M |
| September 30, 2015 | 22.74M |
| June 30, 2015 | 24.38M |
| March 31, 2015 | 22.62M |
| December 31, 2014 | 16.80M |
| September 30, 2014 | 9.357M |
| June 30, 2014 | 2.136M |
| March 31, 2014 | 0.2017M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Anika Therapeutics, Inc. | 5.977M |
| Perspective Therapeutics, Inc. | -93.07M |
| ABVC BioPharma, Inc. | -2.691M |
| Enovis Corp. | 270.10M |
| Edwards Lifesciences Corp. | 1.720B |